JP5681219B2 - 尿管感染症のための分子マーカー - Google Patents

尿管感染症のための分子マーカー Download PDF

Info

Publication number
JP5681219B2
JP5681219B2 JP2012557648A JP2012557648A JP5681219B2 JP 5681219 B2 JP5681219 B2 JP 5681219B2 JP 2012557648 A JP2012557648 A JP 2012557648A JP 2012557648 A JP2012557648 A JP 2012557648A JP 5681219 B2 JP5681219 B2 JP 5681219B2
Authority
JP
Japan
Prior art keywords
procalcitonin
urine
concentration
urinary tract
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012557648A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013522618A (ja
JP2013522618A5 (https=
Inventor
ジウンタ フランチェスコ
ジウンタ フランチェスコ
フォルフィリ フランチェスコ
フォルフィリ フランチェスコ
セリ ジャダ
セリ ジャダ
Original Assignee
ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング
ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング, ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング filed Critical ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング
Publication of JP2013522618A publication Critical patent/JP2013522618A/ja
Publication of JP2013522618A5 publication Critical patent/JP2013522618A5/ja
Application granted granted Critical
Publication of JP5681219B2 publication Critical patent/JP5681219B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/585—Calcitonins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/348—Urinary tract infections

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2012557648A 2010-03-18 2011-03-15 尿管感染症のための分子マーカー Active JP5681219B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM2010A000121 2010-03-18
IT000121A ITRM20100121A1 (it) 2010-03-18 2010-03-18 Marcatori molecolari per infezioni delle vie urinarie.
PCT/IB2011/051073 WO2011114287A2 (en) 2010-03-18 2011-03-15 Molecular markers for urinary tract infections

Publications (3)

Publication Number Publication Date
JP2013522618A JP2013522618A (ja) 2013-06-13
JP2013522618A5 JP2013522618A5 (https=) 2014-11-13
JP5681219B2 true JP5681219B2 (ja) 2015-03-04

Family

ID=42630320

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012557648A Active JP5681219B2 (ja) 2010-03-18 2011-03-15 尿管感染症のための分子マーカー

Country Status (10)

Country Link
US (2) US8748195B2 (https=)
EP (1) EP2548031B1 (https=)
JP (1) JP5681219B2 (https=)
CN (1) CN102939542B (https=)
BR (1) BR112012023485B1 (https=)
ES (1) ES2484720T3 (https=)
IT (1) ITRM20100121A1 (https=)
RU (1) RU2611371C2 (https=)
WO (1) WO2011114287A2 (https=)
ZA (1) ZA201206633B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2592228C2 (ru) * 2014-04-10 2016-07-20 Владимир Игоревич Павлов Способ (варианты) и набор для диагностики инфекции мочевыводящих путей, способ лечения и определения предрасположенности к инфекции мочевыводящих путей
RU2679629C1 (ru) * 2018-07-05 2019-02-12 Антонина Ни Способ диагностики воспалительного процесса органов мочевыделительной системы у детей раннего возраста
RU2724186C1 (ru) * 2020-01-23 2020-06-22 Наталья Борисовна Гусева Способ лечения детей раннего возраста с рецидивирующей инфекцией мочевой системы
RU2766811C1 (ru) * 2021-06-22 2022-03-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Тихоокеанский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ применения маркеров бактериального воспаления для диагностики инфекции мочевыводящих путей у детей первых трех лет жизни

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
CA2623523C (en) * 2005-09-28 2019-02-12 Becton, Dickinson And Company Detection of lysophosphatidylcholine for prognosis or diagnosis of a systemic inflammatory condition
DE102007009751A1 (de) * 2007-02-28 2008-09-04 B.R.A.H.M.S Aktiengesellschaft Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens
CN103123359B (zh) * 2007-08-03 2015-07-29 B.R.A.H.M.S有限公司 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用
US8383332B2 (en) * 2009-10-13 2013-02-26 B.R.A.H.M.S. Gmbh Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack
EP2545379B1 (en) * 2010-03-08 2015-09-30 B.R.A.H.M.S GmbH Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints
CN103096816B (zh) * 2010-05-04 2016-10-12 伊西康有限责任公司 用于产生自固位缝线的激光切割系统和方法

Also Published As

Publication number Publication date
US8748195B2 (en) 2014-06-10
CN102939542A (zh) 2013-02-20
HK1180392A1 (en) 2013-10-18
JP2013522618A (ja) 2013-06-13
ZA201206633B (en) 2015-04-29
WO2011114287A3 (en) 2011-12-15
RU2012144233A (ru) 2014-04-27
US20140242725A1 (en) 2014-08-28
ES2484720T3 (es) 2014-08-12
ITRM20100121A1 (it) 2011-09-19
BR112012023485A2 (pt) 2016-05-24
BR112012023485B1 (pt) 2020-03-17
WO2011114287A2 (en) 2011-09-22
RU2611371C2 (ru) 2017-02-21
CN102939542B (zh) 2015-07-08
US20130084650A1 (en) 2013-04-04
EP2548031A2 (en) 2013-01-23
EP2548031B1 (en) 2014-05-21

Similar Documents

Publication Publication Date Title
Horonenko et al. Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report
Luyt et al. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia
US11041864B2 (en) Method for prediction of prognosis of sepsis
Nakamura et al. Comparison of accuracy of presepsin and procalcitonin concentrations in diagnosing sepsis in patients with and without acute kidney injury
US20140120174A1 (en) Methods of prognosis and diagnosis of sepsis
JP5681219B2 (ja) 尿管感染症のための分子マーカー
EP4052042A1 (en) Sepsis management
US20130149725A1 (en) Methods and compositions for diagnosis of urosepsis and urinary tract infection
CN118638739B (zh) Gsdmd在胸痛相关疾病诊断及疗效评估上的用途
Pastuszczak et al. Association of CSF glucose concentration with neurosyphilis diagnosis
JP7379368B2 (ja) 歯肉炎の診断方法、使用、キット
US20140273032A1 (en) Compositions and methods for diagnosis of schizophrenia
Lee et al. Role of the urinary N-acetyl-beta-D-glucosaminidase/creatinine (NAG/Cr) ratio in discriminating between true and false pyuria in sterile urine bag specimens
HK1180392B (en) Molecular markers for urinary tract infections
US20100304411A1 (en) Endogenous Morphine or a Naturally Occurring Metabolite Thereof as a Marker for Infection
Salleeh et al. Duration of fever affects the likelihood of a positive bag urinalysis or catheter culture in young children
KR102807388B1 (ko) 핵산 기반의 측면 흐름 분석을 이용한 옴진드기의 감염 진단용 정보 제공 방법
Kadari et al. Correlation of urinary neutrophil gelatinase-associated lipocalin levels as an early diagnostic marker for acute kidney injury in patients with sepsis
JPH1132793A (ja) 尿路感染症の診断キット
Nnodim Evaluation Of C-Reactive Protein In Urinary Tract Infected Patients Attending Madonna University Teaching Hospital
西脇亮 et al. Elevated plasma and bile levels of corisin, a microbiotaderived proapoptotic peptide, in patients with severe acute cholangitis
Arina et al. Serum Procalcitoninis an Early and Reliable Diagnostic Marker for Diagnosis of Urinary Tract Infection
HK40029189A (en) Proadrenomedullin as indicator for renal replacement therapy in critically ill patients

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130802

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140318

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140319

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140618

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140625

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20140917

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20141209

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150108

R150 Certificate of patent or registration of utility model

Ref document number: 5681219

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250